XYZ Pharmacy
Log in

Wegovy (Semaglutide) Injection Pen

by Curely Essentials

Purchase Type

XYZ Pharmacy Credits+£42.50

About this medication

Wegovy (semaglutide 2.4mg) is a GLP-1 receptor agonist licensed for chronic weight management alongside a reduced-calorie diet and increased physical activity. It works by mimicking the GLP-1 hormone, reducing appetite and calorie intake. Each FlexTouch pre-filled pen delivers a single weekly subcutaneous dose. Treatment follows a 16-week dose escalation: 0.25mg (weeks 1-4) → 0.5mg (weeks 5-8) → 1mg (weeks 9-12) → 1.7mg (weeks 13-16) → 2.4mg maintenance dose. In the STEP 1 clinical trial, patients lost an average of 14.9% of body weight over 68 weeks.

UK Licensed medication
Free next-day delivery
Ongoing support
UK Licensed medication
Free next-day delivery
Ongoing support

What is Semaglutide (Wegovy)?

Semaglutide, marketed as Wegovy for weight management, is a GLP-1 receptor agonist. It mimics the hormone GLP-1, which is naturally released after eating. This helps regulate appetite by making you feel fuller sooner and for longer, reducing overall food intake.

Wegovy is administered as a once-weekly subcutaneous injection and is clinically proven to help patients achieve significant and sustained weight loss when combined with a reduced-calorie diet and increased physical activity.

Dose Escalation Schedule

Wegovy follows a gradual dose increase schedule to minimise side effects:

Weeks 1-4: 0.25mg | Weeks 5-8: 0.5mg | Weeks 9-12: 1mg | Weeks 13-16: 1.7mg | Week 17 onwards: 2.4mg (maintenance dose)

It is important to follow the escalation schedule. Do not increase your dose faster than recommended. Your prescriber will monitor your response at each stage.

Everybody is different and so is every treatment at XYZ Pharmacy

Based on your health history, BMI and personal goals, we'll recommend the one that's right for you.

Wegovy (Semaglutide) Injection Pen

Wegovy (semaglutide) is a once-weekly injectable GLP-1 receptor agonist clinically proven for long-term weight management in adults.

PriceFrom £169.99
Active Ingredientsemaglutide
Dosage0.25mg - 2.4mg
PenOnce a week
Explore Wegovy (Semaglutide) Injection Pen

Wegovy (Semaglutide) Injection Pen FAQ

Both contain semaglutide, but Wegovy is specifically licensed for weight management at a higher maintenance dose (2.4mg weekly), while Ozempic is licensed for type 2 diabetes at lower doses (up to 1mg weekly). They work in the same way but are prescribed for different purposes.